Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
5.226 ^DKK	-17.44%		-12.99%	+11.60%

23/05	Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024
17/05	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

CS MEDICA A/S Reaffirms Revenue Guidance for the Fiscal Year 2022

February 18, 2022 at 03:16 pm IST

CS MEDICA A/S reaffirmed revenue guidance for the fiscal year 2022. For the year, The company maintained revenue expectation of DKK 50 million, with the majority of the target to be realized in the latter half of the year.

Latest news about CS MEDICA A/S

Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	23/05
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	17/05	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	30/04	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	22/04	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	12/04
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04/04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	21/02
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	20/02	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02/02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	26/01	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	27/12	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	05/12
CS Medica A/S Announces Financial Year Change	22/11	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	22/11	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	22/11	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/23/31	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/23/12	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/23/10	CI
CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/23/14	CI
CS Medica Secures Denmark Patent for Nasal Spray	30/23/30	MT
Transcript : CS Medica A/S, Q3 2023 Earnings Call, Aug 08, 2023	08/23/08
CS MEDICA A/S Announces Establishment of CANNORDIC India Pvt. Ltd. to Expand Presence in India	14/23/14	CI
CS Medica A/S Signs New Own-Label Agreement on Pain Patch	21/23/21	CI
CS Medica Signs Deal for Future Compliance for CE-marked Medical Devices with CBD in EU	16/23/16	MT
CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body	15/23/15	CI

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar